SCHEMBL1660040

SCHEMBL1660040

CC(F)S(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43258 0.75
SCHEMBL240693 0.75
SCHEMBL776997 0.72
SCHEMBL9710368 0.72 CA2 (0.44)
SCHEMBL11520685 0.72 CA2 (0.42)
SCHEMBL24593068 0.72
SCHEMBL1615370 0.72
SCHEMBL3085455 0.72
Hydrochloric Acid SCHEMBL1291216 0.72
SCHEMBL2129023 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488031-A1 DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-08-22 EP claimed
WO-2011046774-A1 DIARYL ETHER DERIVATIVES AS NOTCH SPARING GAMMA SECRETASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-04-21 WO claimed
JP-3068550-A None JP disclosed
US-12503475-B2 Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists CENTESSA PHARMACEUTICALS (UK) LIMITED (GB) 2025-12-23 US disclosed
US-20250289828-A1 MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES CENTESSA PHARMACEUTICALS UK LTD (GB) 2025-09-18 US disclosed
US-20250236629-A1 MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED USES OXFORD FINANCE LLC 2025-07-24 US disclosed
CN-118853260-A Lubricating oil anti-emulsifying agent and preparation method and application thereof 中山市富日印刷材料有限公司 2024-10-29 CN disclosed
US-20230271973-A1 BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS CENTESSA PHARMACEUTICALS (OREXIA) LIMITED (GB) 2023-08-31 US disclosed
US-20230271973-A1 BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS CENTESSA PHARMACEUTICALS (OREXIA) LIMITED (GB) 2023-08-31 US disclosed
US-20230271973-A1 BICYCLIC-HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS CENTESSA PHARMACEUTICALS (OREXIA) LIMITED (GB) 2023-08-31 US disclosed
CN-116583502-A Bicyclic-heterocyclic derivatives and their use as orexin-2 receptor agonists 欧瑞夏治疗有限公司 2023-08-11 CN disclosed
CN-112701354-A Electrolyte of lithium-sulfur battery and preparation method and application thereof 广东邦普循环科技有限公司 2021-04-23 CN disclosed
CN-101801949-B Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2014-09-24 CN disclosed
EP-2440527-A1 PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE Topo Target A/S (DK) 2012-04-18 EP disclosed
WO-2010142735-A1 PYRIDINYL DERIVATIVES AS INHIBITORS OF ENZYME NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE TOPOTARGET A/S (DK) 2010-12-16 WO disclosed
CN-101516850-A Heteroaryl compounds useful as inhibitors of E1 activating enzyme MILLENNIUM PHARM INC (US) 2009-08-26 CN disclosed
JP-H0368550-A FLUORINE-CONTAINING SULFONAMIDE DERIVATIVE AND INSECTICIDE AND ACARICIDE CENTRAL GLASS CO LTD 1991-03-25 JP disclosed